Stable Pharmaceutical Drug Aerosols

  • Published: Aug 14, 2008
  • Earliest Priority: Feb 09 2007
  • Family: 12
  • Cited Works: 0
  • Cited by: 5
  • Cites: 7
  • Additional Info: Full text
Abstract

Various aspects of the present invention provide for methods of manufacturing a pharmaceutical drug product, which include storing a container at a temperature greater than ambient conditions for at least about seven days and conducting release testing on the container after storing. Products manufactured by this method have a more consistent fine particle size distribution (FSD) and fine particle fraction (FPF) at ambient conditions and at accelerated stability conditions over the life of the drug product. Advantageously, such products may more reliably and regularly pass testing requirements as required for an approved drug product by regulatory authorities such as the United States Food and Drug Administration (USFDA).


Claims
Download PDF
Document Preview
Document History
  • Publication: Aug 14, 2008
  • Application: Feb 9, 2007
    WO US 2007/0003637 W
  • Priority: Feb 9, 2007
    US US 2007/0003637 W

Download Citation


Sign in to the Lens

Feedback